Skip to main content
Erschienen in: Cancer Causes & Control 4/2013

01.04.2013 | Original paper

The 2011–2016 Transdisciplinary Research on Energetics and Cancer (TREC) Initiative: Rationale and Design

verfasst von: Ruth E. Patterson, Graham A. Colditz, Frank B. Hu, Kathryn H. Schmitz, Rexford S. Ahima, Ross C. Brownson, Kenneth R. Carson, Jorge E. Chavarro, Lewis A. Chodosh, Sarah Gehlert, Jeff Gill, Karen Glanz, Debra Haire-Joshu, Karen Louise Herbst, Christine M. Hoehner, Peter S. Hovmand, Melinda L. Irwin, Linda A. Jacobs, Aimee S. James, Lee W. Jones, Jacqueline Kerr, Adam S. Kibel, Irena B. King, Jennifer A. Ligibel, Jeffrey A. Meyerhardt, Loki Natarajan, Marian L. Neuhouser, Jerrold M. Olefsky, Enola K. Proctor, Susan Redline, Cheryl L. Rock, Bernard Rosner, David B. Sarwer, J. Sanford Schwartz, Dorothy D. Sears, Howard D. Sesso, Meir J. Stampfer, S. V. Subramanian, Elsie M. Taveras, Julia Tchou, Beti Thompson, Andrea B. Troxel, Marianne Wessling-Resnick, Kathleen Y. Wolin, Mark D. Thornquist

Erschienen in: Cancer Causes & Control | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Recognition of the complex, multidimensional relationship between excess adiposity and cancer control outcomes has motivated the scientific community to seek new research models and paradigms.

Methods

The National Cancer Institute developed an innovative concept to establish a center grant mechanism in nutrition, energetics, and physical activity, referred to as the Transdisciplinary Research on Energetics and Cancer (TREC) Initiative. This paper gives an overview of the 2011–2016 TREC Collaborative Network and the 15 research projects being conducted at the centers.

Results

Four academic institutions were awarded TREC center grants in 2011: Harvard University, University of California San Diego, University of Pennsylvania, and Washington University in St. Louis. The Fred Hutchinson Cancer Research Center is the Coordination Center. The TREC research portfolio includes three animal studies, three cohort studies, four randomized clinical trials, one cross-sectional study, and two modeling studies. Disciplines represented by TREC investigators include basic science, endocrinology, epidemiology, biostatistics, behavior, medicine, nutrition, physical activity, genetics, engineering, health economics, and computer science. Approximately 41,000 participants will be involved in these studies, including children, healthy adults, and breast and prostate cancer survivors. Outcomes include biomarkers of cancer risk, changes in weight and physical activity, persistent adverse treatment effects (e.g., lymphedema, urinary and sexual function), and breast and prostate cancer mortality.

Conclusion

The NIH Science of Team Science group will evaluate the value added by this collaborative science. However, the most important outcome will be whether this transdisciplinary initiative improves the health of Americans at risk of cancer as well as cancer survivors.
Literatur
1.
Zurück zum Zitat Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307:91–97CrossRef Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307:91–97CrossRef
2.
Zurück zum Zitat Ogden CL, Carroll MD, Kit BK, Flegal KM (2012) Prevalence of obesity and trends in the distribution of body mass index among US children and adolescents. JAMA 307:83–90CrossRef Ogden CL, Carroll MD, Kit BK, Flegal KM (2012) Prevalence of obesity and trends in the distribution of body mass index among US children and adolescents. JAMA 307:83–90CrossRef
3.
Zurück zum Zitat Finkelstein EA, Trogdon JG, Cohen JW, Dietz W (2009) Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 28(5):w822–w831CrossRef Finkelstein EA, Trogdon JG, Cohen JW, Dietz W (2009) Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 28(5):w822–w831CrossRef
4.
Zurück zum Zitat Basen-Engquist K, Chang M (2011) Obesity and cancer risk: recent review and evidence. Curr Oncol Rep 13:71–76PubMedCrossRef Basen-Engquist K, Chang M (2011) Obesity and cancer risk: recent review and evidence. Curr Oncol Rep 13:71–76PubMedCrossRef
6.
Zurück zum Zitat Pan SY, DesMeules M (2009) Energy intake, physical activity, energy balance, and cancer: epidemiologic evidence. Methods Mol Biol 472:191–215PubMedCrossRef Pan SY, DesMeules M (2009) Energy intake, physical activity, energy balance, and cancer: epidemiologic evidence. Methods Mol Biol 472:191–215PubMedCrossRef
7.
Zurück zum Zitat Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3:565–574PubMedCrossRef Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3:565–574PubMedCrossRef
8.
Zurück zum Zitat Winzer BM, Whiteman DC, Reeves MM, Paratz JD (2011) Physical activity and cancer prevention: a systematic review of clinical trials. Cancer Causes Control 22:811–826PubMedCrossRef Winzer BM, Whiteman DC, Reeves MM, Paratz JD (2011) Physical activity and cancer prevention: a systematic review of clinical trials. Cancer Causes Control 22:811–826PubMedCrossRef
9.
Zurück zum Zitat Davies NJ, Batehup L, Thomas R (2011) The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer 1:S52–S73CrossRef Davies NJ, Batehup L, Thomas R (2011) The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer 1:S52–S73CrossRef
10.
Zurück zum Zitat Friedenreich CM, Neilson HK, Lynch BM (2010) State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer 46:2593–2604PubMedCrossRef Friedenreich CM, Neilson HK, Lynch BM (2010) State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer 46:2593–2604PubMedCrossRef
11.
Zurück zum Zitat Ballard-Barbash R, Hunsberger S, Alciati MH et al (2009) Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations. J Natl Cancer Inst 101:630–643PubMedCrossRef Ballard-Barbash R, Hunsberger S, Alciati MH et al (2009) Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations. J Natl Cancer Inst 101:630–643PubMedCrossRef
12.
Zurück zum Zitat Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH (2010) An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surv 4:87–100CrossRef Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH (2010) An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surv 4:87–100CrossRef
13.
Zurück zum Zitat Patterson RE, Cadmus LA, Emond JA, Pierce JP (2010) Physical activity, diet, adiposity and breast cancer prognosis: a review of the epidemiologic literature. Maturitas 66:5–15PubMedCrossRef Patterson RE, Cadmus LA, Emond JA, Pierce JP (2010) Physical activity, diet, adiposity and breast cancer prognosis: a review of the epidemiologic literature. Maturitas 66:5–15PubMedCrossRef
14.
Zurück zum Zitat Schmitz KH, Courneya KS, Matthews C et al (2010) American college of sports medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426PubMedCrossRef Schmitz KH, Courneya KS, Matthews C et al (2010) American college of sports medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426PubMedCrossRef
15.
Zurück zum Zitat Jones LW, Demark-Wahnefried W (2006) Diet, exercise, and complementary therapies after primary treatment for cancer. Lancet Oncol 7:1017–1026PubMedCrossRef Jones LW, Demark-Wahnefried W (2006) Diet, exercise, and complementary therapies after primary treatment for cancer. Lancet Oncol 7:1017–1026PubMedCrossRef
16.
Zurück zum Zitat Hewitt M, Greenfield S, Stovall E (2006) From cancer patient to cancer survivor: lost in transition. The National Academies Press, Washington Hewitt M, Greenfield S, Stovall E (2006) From cancer patient to cancer survivor: lost in transition. The National Academies Press, Washington
17.
Zurück zum Zitat Harvey AE, Lashinger LM, Hursting SD (2011) The growing challenge of obesity and cancer: an inflammatory issue. Ann NY Acad Sci 1229:45–52PubMedCrossRef Harvey AE, Lashinger LM, Hursting SD (2011) The growing challenge of obesity and cancer: an inflammatory issue. Ann NY Acad Sci 1229:45–52PubMedCrossRef
18.
Zurück zum Zitat Gallagher EJ, Fierz Y, Ferguson RD, LeRoith D (2010) The pathway from diabetes and obesity to cancer, on the route to targeted therapy. Endocr Pract 16:864–873PubMedCrossRef Gallagher EJ, Fierz Y, Ferguson RD, LeRoith D (2010) The pathway from diabetes and obesity to cancer, on the route to targeted therapy. Endocr Pract 16:864–873PubMedCrossRef
19.
Zurück zum Zitat Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61:301–316PubMedCrossRef Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61:301–316PubMedCrossRef
20.
Zurück zum Zitat Tsugane S, Inoue M (2010) Insulin resistance and cancer: epidemiological evidence. Cancer Sci 101:1073–1079PubMedCrossRef Tsugane S, Inoue M (2010) Insulin resistance and cancer: epidemiological evidence. Cancer Sci 101:1073–1079PubMedCrossRef
21.
Zurück zum Zitat Lynch BM, Neilson HK, Friedenreich CM (2011) Physical activity and breast cancer prevention. Recent Results Cancer Res 186:13–42PubMedCrossRef Lynch BM, Neilson HK, Friedenreich CM (2011) Physical activity and breast cancer prevention. Recent Results Cancer Res 186:13–42PubMedCrossRef
22.
Zurück zum Zitat Stokols D, Hall KL, Taylor BK, Moser RP (2008) The science of team science. Overview of the field and introduction to the supplement. Am J Prev Med 35:S77–S89PubMedCrossRef Stokols D, Hall KL, Taylor BK, Moser RP (2008) The science of team science. Overview of the field and introduction to the supplement. Am J Prev Med 35:S77–S89PubMedCrossRef
23.
Zurück zum Zitat Croyle RT (2008) The National Cancer Institute’s transdisciplinary centers initiatives and the need for building a science of team science. Am J Prev Med 35:S90–S93PubMedCrossRef Croyle RT (2008) The National Cancer Institute’s transdisciplinary centers initiatives and the need for building a science of team science. Am J Prev Med 35:S90–S93PubMedCrossRef
24.
Zurück zum Zitat Warnecke RB, Oh A, Breen N, Gehlert S, Paskett E, Tucker KL, Lurie N, Rebbeck T, Goodwin J, Flack J, Srinivasan S, Kerner J, Heurtin-Roberts S, Abeles R, Tyson FL, Patmios G, Hiatt RA (2008) Approaching health disparities from a population perspective: the National Institutes of Health Centers for population health and health disparities. Am J Public Health 98(9):1608–1615PubMedCrossRef Warnecke RB, Oh A, Breen N, Gehlert S, Paskett E, Tucker KL, Lurie N, Rebbeck T, Goodwin J, Flack J, Srinivasan S, Kerner J, Heurtin-Roberts S, Abeles R, Tyson FL, Patmios G, Hiatt RA (2008) Approaching health disparities from a population perspective: the National Institutes of Health Centers for population health and health disparities. Am J Public Health 98(9):1608–1615PubMedCrossRef
25.
Zurück zum Zitat Abrams DB, Leslie F, Mermelstein R, Kobus K, Clayton RR (2003) Transdisciplinary tobacco use research. Nicotine Tob Res 5(Suppl 1):S5–S10PubMedCrossRef Abrams DB, Leslie F, Mermelstein R, Kobus K, Clayton RR (2003) Transdisciplinary tobacco use research. Nicotine Tob Res 5(Suppl 1):S5–S10PubMedCrossRef
26.
Zurück zum Zitat Hall KL, Stokols D, Stipelman BA, Vogel AL, Feng A, Masimore B, Morgan G, Moser RP, Marcus SE, Berrigan D (2012) Assessing the value of team science: a study comparing center- and investigator-initiated grants. Am J Prev Med 42(2):157–163PubMedCrossRef Hall KL, Stokols D, Stipelman BA, Vogel AL, Feng A, Masimore B, Morgan G, Moser RP, Marcus SE, Berrigan D (2012) Assessing the value of team science: a study comparing center- and investigator-initiated grants. Am J Prev Med 42(2):157–163PubMedCrossRef
27.
Zurück zum Zitat Rimer BK, Abrams DB (2012) Present and future horizons for transdisciplinary research. Am J Prev Med 42(2):200–201PubMedCrossRef Rimer BK, Abrams DB (2012) Present and future horizons for transdisciplinary research. Am J Prev Med 42(2):200–201PubMedCrossRef
28.
Zurück zum Zitat Vogel AL, Feng A, Oh A, Hall KL, Stipelman B, Okamoto J, Stokols D, Moser RP, Perna F, Nebeling L (2012) Influences of a National Cancer Institute transdisciplinary research and training initiative on trainees’ transdisciplinary research competencies and scholarly productivity. Transl Behav Med 4(2):459–468 Vogel AL, Feng A, Oh A, Hall KL, Stipelman B, Okamoto J, Stokols D, Moser RP, Perna F, Nebeling L (2012) Influences of a National Cancer Institute transdisciplinary research and training initiative on trainees’ transdisciplinary research competencies and scholarly productivity. Transl Behav Med 4(2):459–468
29.
Zurück zum Zitat Stokols D, Hall KL, Vogel AL (2012) Transdisciplinary public health: definitions, core characteristics, and strategies for success. In: Haire-Joshu D, McBride TD (eds) Transdisciplinary public health: research, methods, and practice. Jossey-Bass, San Francisco Stokols D, Hall KL, Vogel AL (2012) Transdisciplinary public health: definitions, core characteristics, and strategies for success. In: Haire-Joshu D, McBride TD (eds) Transdisciplinary public health: research, methods, and practice. Jossey-Bass, San Francisco
30.
Zurück zum Zitat Hall KL, Stokols D, Moser RP et al (2008) The collaborative readiness of transdisciplinary research teams and centers. Findings from the National Cancer Institute’s TREC year-one evaluation study. Am J Prev Med 35:S161–S172PubMedCrossRef Hall KL, Stokols D, Moser RP et al (2008) The collaborative readiness of transdisciplinary research teams and centers. Findings from the National Cancer Institute’s TREC year-one evaluation study. Am J Prev Med 35:S161–S172PubMedCrossRef
31.
Zurück zum Zitat Neuhouser ML, Schwartz Y, Wang C, Breymeyer K, Coronado G, Wang CY, Noar K, Song X, Lampe JW (2012) A low-glycemic load diet reduces serum C-reactive protein and modestly increases adiponectin in overweight and obese adults. J Nutr 142(2):369–374PubMedCrossRef Neuhouser ML, Schwartz Y, Wang C, Breymeyer K, Coronado G, Wang CY, Noar K, Song X, Lampe JW (2012) A low-glycemic load diet reduces serum C-reactive protein and modestly increases adiponectin in overweight and obese adults. J Nutr 142(2):369–374PubMedCrossRef
32.
Zurück zum Zitat Behan JW, Yun JP, Proektor MP, Ehsanipour EA, Arutyunyan A, Moses AS, Avramis VI, Louie SG, Butturini A, Heisterkamp N, Mittelman SD (2009) Adipocytes impair leukemia treatment in mice. Cancer Res 19:7867–7874CrossRef Behan JW, Yun JP, Proektor MP, Ehsanipour EA, Arutyunyan A, Moses AS, Avramis VI, Louie SG, Butturini A, Heisterkamp N, Mittelman SD (2009) Adipocytes impair leukemia treatment in mice. Cancer Res 19:7867–7874CrossRef
33.
Zurück zum Zitat Campbell PT, Gross MD, Potter JD, Schmitz KH, Duggan C, McTiernan A, Ulrich CM (2010) Effect of exercise on oxidative stress: a 12-month randomized, controlled trial. Med Sci Sports Exerc 42(8):1448–1453PubMedCrossRef Campbell PT, Gross MD, Potter JD, Schmitz KH, Duggan C, McTiernan A, Ulrich CM (2010) Effect of exercise on oxidative stress: a 12-month randomized, controlled trial. Med Sci Sports Exerc 42(8):1448–1453PubMedCrossRef
34.
Zurück zum Zitat Thompson CL, Larkin EK, Patel S, Berger NA, Redline S, Li L (2011) Short duration of sleep increases risk of colorectal adenoma. Cancer 117(4):841–847PubMedCrossRef Thompson CL, Larkin EK, Patel S, Berger NA, Redline S, Li L (2011) Short duration of sleep increases risk of colorectal adenoma. Cancer 117(4):841–847PubMedCrossRef
35.
Zurück zum Zitat Arikawa AY, O’Dougherty M, Kaufman B, Thomas W, Warren M, Kurzer M, Schmitz KH (2010) Women in steady exercise research (WISER): study design and methods. Contemp Clin Trials 31:457–465PubMedCrossRef Arikawa AY, O’Dougherty M, Kaufman B, Thomas W, Warren M, Kurzer M, Schmitz KH (2010) Women in steady exercise research (WISER): study design and methods. Contemp Clin Trials 31:457–465PubMedCrossRef
36.
Zurück zum Zitat Arikawa AY, Kurzer MS, Thomas W, Schmitz KH (2010) No effect of exercise on insulin-like growth factor (IGF)-1, insulin and glucose in young women participating in a 16-week randomized controlled trial. Cancer Epidemiol Biomark Prev 19:2987–2990CrossRef Arikawa AY, Kurzer MS, Thomas W, Schmitz KH (2010) No effect of exercise on insulin-like growth factor (IGF)-1, insulin and glucose in young women participating in a 16-week randomized controlled trial. Cancer Epidemiol Biomark Prev 19:2987–2990CrossRef
37.
Zurück zum Zitat Arikawa AY, Thomas W, Schmitz KH, Kurzer MS (2011) Sixteen weeks of exercise reduces C-reactive protein levels in young women. Med Sci Sports Exerc 43:1002–1009PubMedCrossRef Arikawa AY, Thomas W, Schmitz KH, Kurzer MS (2011) Sixteen weeks of exercise reduces C-reactive protein levels in young women. Med Sci Sports Exerc 43:1002–1009PubMedCrossRef
38.
Zurück zum Zitat Smith AJ, Phipps WR, Arikawa AY, O’Dougherty M, Kaufman B, Thomas W, Schmitz KH, Kurzer MS (2011) Effects of aerobic exercise on premenopausal sex hormone levels: results of the WISER study, a randomized clinical trial in healthy, sedentary, eumenorrheic women. Cancer Epidemiol Biomark Prev 20:1098–1106CrossRef Smith AJ, Phipps WR, Arikawa AY, O’Dougherty M, Kaufman B, Thomas W, Schmitz KH, Kurzer MS (2011) Effects of aerobic exercise on premenopausal sex hormone levels: results of the WISER study, a randomized clinical trial in healthy, sedentary, eumenorrheic women. Cancer Epidemiol Biomark Prev 20:1098–1106CrossRef
39.
Zurück zum Zitat Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, Grant LL, Bryan CJ, Williams-Smith CT, Greene QP (2009) Weight lifting in women with breast cancer-related lymphedema. New Engl J Med 361:664–673PubMedCrossRef Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, Grant LL, Bryan CJ, Williams-Smith CT, Greene QP (2009) Weight lifting in women with breast cancer-related lymphedema. New Engl J Med 361:664–673PubMedCrossRef
40.
Zurück zum Zitat Schmitz KH, Ahmed RL, Troxel AB, Cheville A, Lewis-Grant L, Smith R, Bryan CJ, Williams-Smith CT, Chittams J (2010) Weight-lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA 304:2699–2705PubMedCrossRef Schmitz KH, Ahmed RL, Troxel AB, Cheville A, Lewis-Grant L, Smith R, Bryan CJ, Williams-Smith CT, Chittams J (2010) Weight-lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA 304:2699–2705PubMedCrossRef
Metadaten
Titel
The 2011–2016 Transdisciplinary Research on Energetics and Cancer (TREC) Initiative: Rationale and Design
verfasst von
Ruth E. Patterson
Graham A. Colditz
Frank B. Hu
Kathryn H. Schmitz
Rexford S. Ahima
Ross C. Brownson
Kenneth R. Carson
Jorge E. Chavarro
Lewis A. Chodosh
Sarah Gehlert
Jeff Gill
Karen Glanz
Debra Haire-Joshu
Karen Louise Herbst
Christine M. Hoehner
Peter S. Hovmand
Melinda L. Irwin
Linda A. Jacobs
Aimee S. James
Lee W. Jones
Jacqueline Kerr
Adam S. Kibel
Irena B. King
Jennifer A. Ligibel
Jeffrey A. Meyerhardt
Loki Natarajan
Marian L. Neuhouser
Jerrold M. Olefsky
Enola K. Proctor
Susan Redline
Cheryl L. Rock
Bernard Rosner
David B. Sarwer
J. Sanford Schwartz
Dorothy D. Sears
Howard D. Sesso
Meir J. Stampfer
S. V. Subramanian
Elsie M. Taveras
Julia Tchou
Beti Thompson
Andrea B. Troxel
Marianne Wessling-Resnick
Kathleen Y. Wolin
Mark D. Thornquist
Publikationsdatum
01.04.2013
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 4/2013
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-013-0150-z

Weitere Artikel der Ausgabe 4/2013

Cancer Causes & Control 4/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.